BioMedicure Investors

BioMedure's work has been supported by over 50 investors/shareholders including but not limiting to the following (due to privacy, some investors/shareholders are not willing to disclose their name at this moment):

  • Yu An, PhD, San Diego, California, USA
  • Paul Caldarazzo, MBA, Sammamish, Washington, USA
  • Susan Caldarazzo, BS, Sammamish, Washington, USA
  • Thomas N. Campbell, MD, Oncology Doctor, San Diego, California, USA
  • Gang Chen, PhD, San Diego, California, USA
  • Lili Chen, Indianapolis, Indiana, USA
  • James R. Clugston, MD, Faculty and Medical Doctor, Gainesville, Florida, USA
  • Boyang Chu, PhD, Nanjing, China
  • Cory Yunxin Cui, PhD, Carmel, Indiana, USA
  • Tucker Cole, MSF, CEO, Raymond, Maine, USA
  • Fuli Du, PhD, San Diego, California, USA
  • Kevin Gellenbeck, PhD, Poway, California, USA
  • Peggy Gellenbeck, BS, Poway, California, USA
  • Wenge Han, PhD, San Diego, California, USA
  • Jackie Li, MS, Vancouver, British Columbia, Canada
  • Jin Li, PhD, San Diego, California, USA
  • Miao Li, MS, San Diego, California, USA
  • Binfeng Liu, PhD, San Diego, California, USA
  • Yan Liu, MBA, Plano, Texas, USA
  • James L. LoPresti, MBA, CEO, Phoenix, Arizona, USA
  • Paula A. LoPresti, MHOM, Phoenix, Arizona, USA
  • Ken Lousenberg, MBA, CEO, Beijing, China
  • Michael McClurg, MBA, San Diego, California, USA
  • John E. O'Donnell III, CEO, Poland, Maine, USA
  • Michael F. O'Donnell, MS, Auburn, Maine, USA
  • Sonia O'Donnell, MS, Auburn, Maine, USA
  • Xiaolin Qi, MS, San Diego, California, USA
  • Yong Qian, PhD, President & CEO of BioMedicure, San Diego, California, USA
  • Kerry Stumpff, Occupational Therapy, Beijing, China
  • Yan Wang, PhD, San Diego, California, USA
  • Anna Xu, MS, Plano, Taxas, USA
  • Qiang Xu, PhD, San Diego, California, USA
  • Jaffrey Zhang, PhD, San Jose, California, USA
  • Libin Zhang, JD, New York City, New York, USA
  • Ning Zhang, PhD, San Diego, California, USA
  • Shiping Zhang, PhD, Beijing, China

BioMedicure was awarded with a IRS-QTDP grant titled "Developing CancerVaccines to prevent and treat cancer including melanoma" for $244,479.24 on October 29th, 2010

If you are interested in investing in BioMedicure, please send your inquiries to invest@biomedicure.com